Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
1.
Health Promot Int ; 16(3): 255-60, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11509461

ABSTRACT

One of the key goals of health promotion strategies in the UK and other developed countries is to reduce the prevalence of cigarette consumption. While overall smoking rates in the UK have fallen over the last few decades, they have barely fallen for the least advantaged adults (Department of Health, 1998a). There is a need for interventions that are suitable for lower socio-economic status (SES) smokers that have undergone rigorous evaluation. This study describes a randomized controlled trial of cognitive behaviour therapy (CBT) with smokers from a deprived area of London. At 6 months follow-up, 21 (17.2%) of 122 participants receiving therapy were abstinent and 14 (11.5%) had reduced cigarette consumption by at least 25% of pre-treatment level. Six (5.6%) of 107 participants in the control group were abstinent and none had reduced consumption. These results suggest that this self-help CBT intervention has the potential to reduce the prevalence of smoking among lower SES smokers.


Subject(s)
Cognitive Behavioral Therapy , Smoking Cessation , Smoking Prevention , Smoking/psychology , Adult , Cognitive Behavioral Therapy/methods , Female , Humans , London , Male , Motivation , Pamphlets , Patient Education as Topic/standards , Self Care/psychology , Smoking Cessation/methods , Smoking Cessation/psychology , Smoking Cessation/statistics & numerical data , Socioeconomic Factors , Treatment Outcome
2.
Alzheimer Dis Assoc Disord ; 15(2): 102-5, 2001.
Article in English | MEDLINE | ID: mdl-11403329

ABSTRACT

The European Union has funded numerous projects on Alzheimer disease and associated disorders (ADAD). In the funding years of 1995 and 1996, six million Euro were spent on ADAD projects. In 1996, 21% of applications were funded. Having had the opportunity to review all these projects, we offer insight into the funding procedure and some of our conclusions from reviewing all these projects.


Subject(s)
Alzheimer Disease/economics , European Union/economics , Research Support as Topic/economics , Europe , Humans
3.
J Med Primatol ; 30(1): 36-45, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11396862

ABSTRACT

The close phylogenetic relationship of macaques to humans has resulted in their widespread use as a preclinical model for bone marrow transplantation and stem cell gene therapy. To facilitate further use of this model, we undertook analysis of hematopoietic cells using multiparametric flow cytometric analysis. Rhesus CD34+CD38- cells displayed a number of characteristics of primitive hematopoietic cells, including low forward and orthogonal scatter and the lack of expression of lineage-specific markers or human lymphocyte antigen-DR. Four-color flow cytometric analysis demonstrated that rhesus CD34+CD38- cells were heterogenous with respect to Thy-1 expression and were CD59dim. Quantitative limiting dilution long-term culture-initiating cell (LTC-IC) analysis demonstrated that CD34+CD38- cells were approximately 150-fold enriched for LTC-IC as compared with unfractionated bone marrow, and occurred at a frequency similar to that previously reported in humans. Thus, as in humans, the CD34+38- population of rhesus macaque bone marrow is enriched for primitive, multipotent hematopoietic progenitor cells.


Subject(s)
Hematopoietic Stem Cells/immunology , Macaca mulatta/immunology , Animals , Antibodies, Monoclonal/analysis , Antigens, CD34/analysis , Bone Marrow/immunology , Disease Models, Animal , Flow Cytometry , Humans , Thymus Gland/immunology
4.
Eur J Public Health ; 11(4): 461-3; author reply 463, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11766495
5.
J Health Psychol ; 5(1): 5-6, 2000 Jan.
Article in English | MEDLINE | ID: mdl-22048818
6.
J Health Psychol ; 5(2): 131-2, 2000 Mar.
Article in English | MEDLINE | ID: mdl-22049001
7.
J Health Psychol ; 5(4): 411, 2000 Jul.
Article in English | MEDLINE | ID: mdl-22049185
8.
Exp Hematol ; 27(3): 496-504, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10089912

ABSTRACT

The ability to culture multipotent hematopoietic progenitor cells for extended periods is of practical importance to both clinical and research efforts involving these cells. Conventional techniques for the extended culture of hematopoietic progenitor cells (HPCs) have proven largely ineffective in sustaining these cells and preserving their multipotency over protracted periods. To overcome barriers to extended HPC culture, numerous alternative approaches, including cytokine augmentation and co-culture with bone marrow stroma, have been explored to enhance HPC maintenance but have generally yielded mixed results. The present study examined the ability of a novel, three-dimensional, tantalum-coated porous biomaterial (TCPB) to support HPC maintenance and multipotency in long-term cultures to which no exogenous cytokines have been added. As a follow-up to previously published short-term HPC cultures in TCPB, we examined the maintenance, phenotype and multipotency of HPCs cultured for up to 6 weeks in the TCPB matrix compared to control systems, including fibronectin-coated plastic, bone marrow stroma cocultures and other three-dimensional materials. These studies indicated that TCPB supports the maintenance of immature progenitors for up to 6 weeks in the absence of supplemented cytokines. Further, the results demonstrate that the TCPB matrix facilitates and enhances HPC maintenance and leads to a 1.5-fold expansion of HPC numbers following 1 week in culture and a 6.7-fold increase in colony-forming ability following 6 weeks in culture in the absence of exogenous cytokines. Under the same conditions, control systems were less able to support progenitor viability and multipotency. These findings point to new approaches that may improve the in vitro preservation of progenitors and may have important implications in clinical areas such as progenitor expansion, bone marrow transplantation and gene therapy.


Subject(s)
Cell Culture Techniques/instrumentation , Hematopoietic Stem Cells/cytology , Biocompatible Materials , Cell Culture Techniques/methods , Cell Differentiation , Cell Division , Cell Lineage , Cells, Cultured , Ceramics , Colony-Forming Units Assay , Evaluation Studies as Topic , Fibronectins , Humans , Immunophenotyping , Microspheres , T-Lymphocytes/cytology , Tantalum , Time Factors
9.
J Health Psychol ; 4(1): 5-8, 1999 Jan.
Article in English | MEDLINE | ID: mdl-22021429
10.
Exp Hematol ; 26(10): 991-9, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9728935

ABSTRACT

Umbilical cord blood contains an abundance of CD34+ hematopoietic progenitor cells and has been used in transplantation as an alternative to adult bone marrow or mobilized peripheral blood. Although efficient myelomonocytic, erythroid, and B lymphoid differentiation has been shown in highly purified cord blood CD34+ mononuclear cells lacking expression of lineage-specific antigens, generation of functional T cells has not been previously documented. Exploiting two recently developed, complementary thymic stromal monolayer systems, we show here that immature hematopoietic progenitor cells (CD34+lineage-) from human and rhesus monkey cord blood mononuclear cells undergo T lymphopoiesis in a manner that recapitulates T cell ontogeny in vivo. After 2 weeks of proliferation, cultures contained myeloid [corrected] cells and discrete populations of CD4+CD8+ (double-positive) immature T lymphocytes, followed after an additional 2 weeks by the appearance of single-positive CD4+CD8- and CD4-CD8+ T cells that coexpressed CD3. The T lymphoid phenotype was confirmed at the transcriptional level by the presence of the lymphoid-restricted genes RAG-2 and T cell receptor. T cells generated from cord blood progenitors in these systems exhibited immunofunction as assessed by alloreactive responses in mixed lymphocyte reactions. These findings were comparable between human and rhesus progenitor cells and closely resemble previous data using adult bone marrow CD34+ cells in these models. Together, these observations demonstrate that cord blood contains abundant lymphoid progenitors that undergo T lymphopoiesis in vitro, suggesting the full multipotentiality of this stem cell source and its validity in investigating T lymphoid differentiation.


Subject(s)
Antigens, CD34/blood , Fetal Blood/immunology , Hematopoietic Stem Cells/immunology , Leukopoiesis/immunology , T-Lymphocytes/cytology , Animals , Cells, Cultured , Humans , Immunophenotyping , Macaca mulatta , Phylogeny , Polymerase Chain Reaction/methods , Stromal Cells/cytology , Thymus Gland/cytology , Thymus Gland/embryology , Transcription, Genetic
11.
J Health Psychol ; 3(1): 149-60, 1998 Jan.
Article in English | MEDLINE | ID: mdl-22021350

ABSTRACT

This Final Report of the European Federation of Professional Psychologists' Associations (EFPPA) Task Force on Health Psychology defines the nature and scope of health psychology and its possible future development to the year 2000 and beyond. Training needs and objectives are specified for professional health psychologists working in Europe. Practical and policy implications of medical progress and societal changes are discussed. The future development of health psychology as a profession depends on putting theory and policy into practice through the implementation of high quality training. Currently there are relatively few European countries where this has yet happened. Training programmes need to be introduced in all European countries within the framework of each member- country's national laws, regulations and practices.

12.
Nat Med ; 3(12): 1337-45, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9396603

ABSTRACT

We previously described a method for isolating murine hematopoietic stem cells capable of reconstituting lethally irradiated recipients, which depends solely on dual-wavelength flow cytometric analysis of murine bone marrow cells stained with the fluorescent DNA-binding dye Hoechst 33342. This method, which appears to rely on the differential ability of stem cells to efflux the Hoechst dye, defines an extremely small and homogeneous population of cells (termed SP cells). We show here that dual-wavelength analysis of Hoechst dye-stained human, rhesus and miniature swine bone marrow cells reveals a small, distinct population of cells that efflux the dye in a manner identical to murine SP cells. Like the murine SP cells, both human and rhesus SP cells are primarily CD34-negative and lineage marker-negative. In vitro culture studies demonstrated that rhesus SP cells are highly enriched for long-term culture-initiating cells (LTC-ICs), an indicator of primitive hematopoietic cells, and have the capacity for differentiation into T cells. Although rhesus SP cells do not initially possess any hematopoietic colony-forming capability, they acquire the ability to form colonies after long-term culture on bone marrow stroma, coincident with their conversion to a CD34-positive phenotype. These studies suggest the existence of a hitherto unrecognized population of hematopoietic stem cells that lack the CD34 surface marker classically associated with primitive hematopoietic cells.


Subject(s)
Antigens, CD34/analysis , Hematopoietic Stem Cells/chemistry , Animals , Benzimidazoles/metabolism , Fluorescent Dyes/metabolism , Humans , Macaca mulatta , Male , Mice , Mice, Inbred C57BL , Species Specificity , Stromal Cells , Swine , Swine, Miniature , Time Factors
13.
Psychooncology ; 6(3): 190-6, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9313284

ABSTRACT

Anxiety levels in a sample of 65 long-term cancer survivors were assessed in a study of the effects of a planned discharge from an oncology clinic. Thirty-one percent of patients scored > or = 8, and 12% > or = 11 on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS), indicating that anxiety rates in patients in long-standing remission do not greatly differ from patients with active disease. Despite the provision of continued support and guaranteed fast-access return to the clinic if necessary, 28% of patients refused to be discharged. Fear that recurrence would not be detected was the reason most frequently cited. Seventy-five percent of these patients were HADS anxiety cases. A second assessment 4-5 months later of the 41 patients who were discharged showed a slight, but non-significant increase in anxiety rates suggesting that anxiety in cancer survivors may be persistent and not related to clinic attendance.


Subject(s)
Anxiety/complications , Neoplasms/psychology , Patient Acceptance of Health Care , Patient Discharge , Survivors/psychology , Adult , Aged , Aged, 80 and over , Chi-Square Distribution , Cross-Sectional Studies , Depression/complications , Female , Humans , Long-Term Care/psychology , Male , Middle Aged , Neoplasms/therapy , Prospective Studies , Sampling Studies
14.
J Virol ; 71(4): 2740-6, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9060627

ABSTRACT

Transduction of hematopoietic stem cells with genes that inhibit human immunodeficiency virus (HIV) replication has the potential to reconstitute immune function in individuals with AIDS. We evaluated the ability of an autoregulated gene, antitat, to inhibit replication of simian immunodeficiency virus (SIV) and HIV type 1 (HIV-1) in hematopoietic cells derived from transduced progenitor cells. The antitat gene expresses an antiviral RNA encoding polymeric Tat activation response elements in combination with an antisense tat moiety under the control of the HIV-1 long terminal repeat. CD34+ hematopoietic progenitor cells were transduced with a retroviral vector containing the antitat gene and then cultured under conditions that support in vitro differentiation of T cells or macrophage-like cells. Rhesus macaque CD4+ T cells and macrophage-like cells derived from CD34+ bone marrow cells transduced with the antitat gene were highly resistant to challenge with SIV, reflecting a 2- to 3-log reduction in peak SIV replication compared with controls. Similarly, human CD4+ T cells derived from CD34+ cord blood cells transduced with antitat were also resistant to infection with HIV-1. No evidence for toxicity of the antitat gene was observed in any of five different lineages derived from transduced hematopoietic cells. These results demonstrate that a candidate therapeutic gene introduced into hematopoietic progenitor cells can retain the ability to inhibit AIDS virus replication following T-cell differentiation and support the potential use of the antitat gene for stem cell gene therapy.


Subject(s)
Antigens, CD34/biosynthesis , CD4-Positive T-Lymphocytes/virology , Gene Products, tat/genetics , HIV-1/physiology , Hematopoietic Stem Cells/immunology , Macrophages/virology , Simian Immunodeficiency Virus/physiology , Transformation, Genetic , Animals , CD4-Positive T-Lymphocytes/immunology , Cell Differentiation , Gene Products, gag/analysis , Genetic Vectors , HIV Core Protein p24/analysis , HIV Long Terminal Repeat , HIV-1/immunology , Hematopoietic Stem Cells/virology , Humans , Macaca mulatta , Macrophages/immunology , Retroviridae/genetics , Simian Immunodeficiency Virus/immunology , Virus Replication , tat Gene Products, Human Immunodeficiency Virus
15.
Gene Ther ; 4(9): 928-36, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9349429

ABSTRACT

Current techniques for the in vitro maintenance of hematopoietic stem cells often lead to loss of pluripotency. Overcoming the technical difficulties that result in alterations in stem cells in vitro has important implications for areas of basic science and clinical medicine such as cell expansion, bone marrow transplantation and gene therapy. Recent insights into hematopoietic stem cell biology have demonstrated that the three-dimensional architecture of the culture environment may influence the maintenance of stem cell pluripotency in vitro. An intriguing hypothesis is that the utilization of three-dimensional culture systems may improve the maintenance and manipulation of these cells in vitro. We report that a novel, three-dimensional, tantalum-coated porous biomaterial (TCPB) may be employed effectively as a hematopoietic progenitor cell culture device that offers distinct advantages over conventional culture systems. Specifically, we demonstrate that the use of TCPB for culturing hematopoietic progenitor cells in the absence of exogenous cytokines results in enhanced hematopoietic progenitor cell survival, improved maintenance of the immature CD34+/38- phenotype, and improved retroviral transduction of CD34+ cells and long-term culture initiating cells (LTCIC), without compromising multipotency, as compared with cultures in plastic dishes or bone marrow stroma. These findings suggest that this three-dimensional culture system may be useful in advancing the in vitro culture and transduction of hematopoietic stem and progenitor cells.


Subject(s)
Genetic Therapy/methods , Hematopoietic Stem Cells , Retroviridae , Animals , Antigens, CD34 , Cell Culture Techniques , Cell Survival , Flow Cytometry , Gene Transfer Techniques , Macaca mulatta
16.
Blood ; 90(12): 4822-31, 1997 Dec 15.
Article in English | MEDLINE | ID: mdl-9389699

ABSTRACT

Evaluation of candidate genes for stem cell gene therapy for acquired immunodeficiency syndrome (AIDS) has been limited by the difficulty of supporting in vitro T-cell differentiation of genetically modified hematopoietic progenitor cells. Using a novel thymic stromal culture technique, we evaluated the ability of a hairpin ribozyme specific for simian immunodeficiency virus (SIV) and human immunodeficiency virus type 2 (HIV-2) to inhibit viral replication in T lymphocytes derived from transduced CD34+ progenitor cells. Retroviral transduction of rhesus macaque CD34+ progenitor cells with a retroviral vector (p9456t) encoding the SIV-specific ribozyme and the selectable marker neomycin phosphotransferase in the presence of bone marrow stroma and in the absence of exogenous cytokines resulted in efficient transduction of both colony-forming units and long-term culture-initiating cells, with transduction efficiencies ranging between 21% and 56%. After transduction, CD34+ cells were cultured on rhesus thymic stromal culture (to support in vitro differentiation of T cells) or in the presence of cytokines (to support differentiation of macrophage-like cells). After expansion and selection with the neomycin analog G418, cells derived from transduced progenitor cells were challenged with SIV. CD4+ T cells derived from CD34+ hematopoietic cells transduced with the ribozyme vector p9456t were highly resistant to challenge with SIV, exhibiting up to a 500-fold decrease in SIV replication, even after high multiplicities of infection. Macrophages derived from CD34+ cells transduced with the 9456 ribozyme exhibited a comparable level of inhibition of SIV replication. These results show that a hairpin ribozyme introduced into CD34+ hematopoietic progenitor cells can retain the ability to inhibit AIDS virus replication after T-cell differentiation and support the feasibility of intracellular immunization of hematopoietic stem cells against infection with HIV and SIV. Protection of multiple hematopoietic lineages with the SIV-specific ribozyme should permit analysis of stem cell gene therapy for AIDS in the SIV/macaque model.


Subject(s)
Acquired Immunodeficiency Syndrome/therapy , Genetic Therapy , Hematopoietic Stem Cells/metabolism , Macrophages/virology , RNA, Catalytic/genetics , Simian Immunodeficiency Virus/physiology , T-Lymphocytes/virology , Animals , Antigens, CD34/analysis , Genetic Vectors , Humans , Immunization , Macaca mulatta , Retroviridae/genetics , Virus Replication
17.
J Health Psychol ; 2(1): 5-7, 1997 Jan.
Article in English | MEDLINE | ID: mdl-22012792
18.
J Health Psychol ; 2(2): 131, 1997 Apr.
Article in English | MEDLINE | ID: mdl-22012988
19.
J Med Primatol ; 25(3): 192-200, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8892040

ABSTRACT

Stable introduction of therapeutic genes into hematopoietic stem cells has the potential to reconstitute immunity in individuals with HIV infection. However, many important questions regarding the safety and efficacy of this approach remain unanswered and may be addressed in a non-human primate model. To facilitate evaluation of expression of foreign genes in T cells derived from transduced hematopoietic progenitor cells, we have established a culture system that supports the differentiation of rhesus macaque and human CD34+ bone marrow derived cells into mature T cells. Thymic stromal monolayers were prepared from the adherent cell fraction of collagenase digested fetal or neonatal thymus. After 10-14 days, purified rhesus CD34+ bone marrow-derived cells cultured on thymic stromal monolayers yielded CD3+CD4+CD8+, CD3+CD4+CD8-, and CD3+CD4-CD8+ cells. Following stimulation with mitogens, these T cells derived from CD34+ cells could be expanded over 1,000-fold and maintained in culture for up to 20 weeks. We next evaluated the ability of rhesus CD34+ cells transduced with a retroviral vector containing the marker gene neo to undergo in vitro T cell differentiation. CD34+ cells transduced in the presence of bone marrow stroma and then cultured on rhesus thymic stroma resulted in T cells containing the retroviral marker gene. These studies should facilitate both in vitro and in vivo studies of hematopoietic stem cell therapeutic strategies for AIDS.


Subject(s)
Acquired Immunodeficiency Syndrome/therapy , Genetic Therapy , Hematopoiesis , Hematopoietic Stem Cells/cytology , T-Lymphocytes , Animals , Animals, Newborn , Antigens, CD/analysis , Antigens, CD34/analysis , Antigens, Differentiation, T-Lymphocyte/analysis , Antigens, Differentiation, T-Lymphocyte/biosynthesis , Antigens, Differentiation, T-Lymphocyte/immunology , Bone Marrow Cells , COS Cells , Cell Differentiation , Cells, Cultured , Fetus , Flow Cytometry , Genes, Reporter , Genetic Vectors , Hematopoietic Stem Cells/immunology , Humans , Immunomagnetic Separation , Kanamycin Kinase , Lymphocyte Activation , Macaca mulatta , Phosphotransferases (Alcohol Group Acceptor)/biosynthesis , Phosphotransferases (Alcohol Group Acceptor)/genetics , Polymerase Chain Reaction , Retroviridae , Stromal Cells , T-Lymphocytes/cytology , T-Lymphocytes/immunology , Thymus Gland/cytology , Thymus Gland/immunology , Transfection/methods
20.
Blood ; 87(10): 4040-8, 1996 May 15.
Article in English | MEDLINE | ID: mdl-8639759

ABSTRACT

Differentiation of hematopoietic progenitor cells into T lymphocytes generally occurs in the unique environment of the thymus, a feature that has hindered efforts to model this process in the laboratory. We now report that thymic stromal cultures from rhesus macaques can support T-cell differentiation of human or rhesus CD34+ progenitor cells. Culture of rhesus or human CD34+ bone marrow-derived cells depleted of CD34+ lymphocytes on rhesus thymic stromal monolayers yielded CD3+CD4+CD8+, CD3+CD4+CD8-, and CD3+CD4-CD8+ cells after 10 to 14 days. In addition to classical T lymphocytes, a discrete population of CD3+CD8loCD16+CD56+ cells was detected after 14 days in cultures inoculated with rhesus CD34+ cells. CD3+ T cells arising from these cultures were not derived from contaminating T cells present in the CD34+ cells used to inoculate thymic stromal monolayers or from the thymic monolayers, as shown by labeling of cells with the lipophilic membrane dye PKH26. Expression of the recombinase activation gene RAG-2, which is selectively expressed in developing lymphocytes, was detectable in thymic cultures inoculated with CD34+ cells but not in CD34+ cells before thymic culture or in thymic stromal monolayers alone. Reverse transcriptase-polymerase chain reaction analysis of T cells derived from thymic stromal cultures of rhesus and human CD34+ cells showed a polyclonal T-cell receptor repertoire. T-cell progeny derived from rhesus CD34+ cells cultured on thymic stroma supported vigorous simian immunodeficiency virus replication in the absence of exogenous mitogenic stimuli. Rhesus thymic stromal cultures provide a convenient means to analyze T-cell differentiation in vitro and may be useful as a model of hematopoietic stem cell therapy for diseases of T cells, including acquired immunodeficiency syndrome.


Subject(s)
DNA-Binding Proteins , Hematopoiesis , Hematopoietic Stem Cells/cytology , Macaca mulatta/physiology , T-Lymphocyte Subsets/cytology , Thymus Gland/cytology , Animals , Antigens, CD34/analysis , Base Sequence , Bone Marrow Cells , CD3 Complex/analysis , Cell Differentiation , Cells, Cultured , Connective Tissue/physiology , Connective Tissue Cells , DNA, Complementary/genetics , Humans , Molecular Sequence Data , Nuclear Proteins , Polymerase Chain Reaction , Proteins/genetics , Proteins/physiology , Receptors, IgG/analysis , Simian Immunodeficiency Virus/physiology , Species Specificity , T-Lymphocyte Subsets/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...